Journey Medical (DERM) Inventory (2020 - 2026)

Journey Medical (DERM) has reported Inventory for 7 consecutive years, with $10.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory fell 20.75% year-over-year to $10.8 million; the trailing twelve-month figure through Jun 2026 stood at $10.8 million (down 20.75% YoY), and the FY2025 full-year result was $10.6 million, down 28.93% from the prior year.
• Inventory declined to $10.8 million in Q2 2026 per DERM's latest filing, from $11.7 million in the prior quarter.
• Across five years, Inventory topped out at $16.2 million in Q1 2022 and bottomed at $10.1 million in Q2 2024.
• Historically, Inventory has averaged $12.9 million across 5 years, with a median of $12.9 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Inventory surged 47.92% in 2022, then fell 28.93% in 2025.
• Over 5 years, Inventory stood at $14.6 million in 2022, then declined by 27.95% to $10.5 million in 2023, then soared by 42.17% to $14.9 million in 2024, then dropped by 28.93% to $10.6 million in 2025, then grew by 1.22% to $10.8 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $10.8 million, $11.7 million, and $10.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.